摘要
目的调查上海市松江区中心医院(以下简称“我院”)联用中成药处方临床使用现状,以提升我院中成药联用的合理使用率。方法利用我院HIS系统,随机抽取我院2022年2月门诊中成药处方6787张,筛选出含有2种或2种以上中成药的处方851张,并对其进行合理性分析。结果在851张联合使用中成药处方中,涉及24个科室,排名前3位的科室分别是骨科[18.45%(157/851)]、神经内科[17.39%(148/851)]及呼吸内科[12.69%(108/851)]。不合理的表现主要为重复用药[63.78%(118/185)]、药性相悖[17.84%(33/185)]和有毒成分联用[17.30%(32/185)]。结论医院中成药联用现象较为普遍,存在一定的不合理联用,需要进一步提高中成药用药监管力度,以尽量减少不合理联用。
Objective To investigate the current situation of clinical use of combined Chinese patent medicines in Songjiang District Central Hospital(our hospital),and to improve the rational utilization rate of combined Chinese patent medicines in our hospital.Methods We randomly selected 6787 prescriptions of outpatient proprietary Chinese medicines in Songjiang District Central Hospital in February 2022 by the HIS system.We screened out 851 prescriptions containing two or more Chinese patent medicines and analyzes their rationality.Results Among the 851 prescriptions for combined use of Chinese patent medicines,24 departments were involved;the top three departments were orthopedics,neurology,and respiratory medicine,accounting for 18.45%(157/851),17.39%(148/851),and 12.69%(108/851),respectively.The unreasonable manifestations mainly included repeated drug use,contradictory drug properties,and combined use of toxic ingredients,accounting for 63.78%(118/185),17.84%(33/185),and 17.30%(32/185),respectively.Conclusions The combined use of Chinese patent medicines in hospitals is common,and there are some irrational combinations.It is necessary to further strengthen the supervision of the use of Chinese patent medicines in order to minimize irrational combinations.
作者
戚留英
Qi Liuying(Department of Pharmacy,Songjiang District Central Hospital,Shanghai 201600,China)
出处
《国际医药卫生导报》
2023年第4期528-531,共4页
International Medicine and Health Guidance News
基金
上海市临床药学重点专科建设项目(区属)[沪卫计药政(2018)9号]。
关键词
中成药联用
处方点评
合理用药
Combination of Chinese patent medicines
Prescription evaluation
Rational administration of drugs
